Prismx Global (501314)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 38% discount to book value: P/B 0.62 vs book value ₹2.18.
• Positive net profit of ₹1 Cr in the latest quarter and 26.72% profit growth on a low base.
• Piotroski F-score of 6/9 suggests no severe near-term balance sheet stress.
• Small market cap of ₹59 Cr leaves room for potential asset unlocking or corporate action.

Concerns

• Latest quarter sales are ₹0 Cr and sales growth is -18.18%, indicating the core trading business is inactive.
• ROE of 1.78% and ROCE of 4.32% show poor returns on capital; book value is not compounding.
• Profit without revenue suggests possible non-operating or one-off income, not sustainable earnings.
• Zero dividend yield and undisclosed promoter holding/debt-equity limit confidence for minority investors.

AI Analysis

Prismx Global is the kind of stock that makes Graham smile and Buffett wince. At ₹1.35, I am buying ₹2.18 of book value for just 62 paise a rupee. That is a genuine discount on the surface, a classic asset play. But my first rule is never to treat a cheap number as a margin of safety until I understand the business underneath. Prismx is a trading and distribution company, and trading businesses rarely have moats. The latest quarter reports sales of ₹0 Cr; full-year sales fell 18.18%. A revenue engine that is silent is not a business, it is a shell. Net profit of ₹1 Cr with zero sales tells me the earnings may come from non-operating income, not durable operations. The P/E of 14.88 and PEG of 0.56 are therefore meaningless because the E is not sustainable. ROE of just 1.78% and ROCE of 4.32% confirm that the company is not earning a satisfactory return on the capital embedded in that book value. Without a double-digit ROE, book value is unlikely to compound, and the discount to book will persist or widen. On the positive side, the Piotroski F-score of 6/9 suggests balance sheet health has not collapsed, and profit growth of 26.72% on a tiny base is easy to achieve. Dividend yield is zero, so I am not being paid to wait. Since promoter holding and debt-equity are not available, I cannot judge whether insiders are aligned or whether there is hidden financial stress. This is a small ₹59 Cr market cap stock. I would only consider it as a speculative asset play after inspecting the balance sheet line by line. If the ₹2.18 book value is real and saleable, there is upside. If it is stuffed with stale inventory or doubtful receivables, the discount is an illusion. In Buffett's words, it is a cigar butt - a cheap price for one or two puffs, but not a wonderful business.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer